← Back to news

Markets

Guggenheim Lifts Target (TGT) PT, Sees Turnaround Gaining Traction

Y

The Average Retiree Brings In $5,455 Monthly but Spends $5,119 — Can You Guess the Expense Taking the Biggest Bite?

Y

Wells Fargo Raises Chubb (CB) PT, Citizens Calls it a Top Pick

Y

Leaders come and go; companies rise and fall. In business, change is the constant.

Y

Bank of America Cuts Pentair (PNR) PT to $88, Sees Weak Q1 Ahead

Y

Truist Lowers GPC Target to $124, Notes Margin Recovery

Y

Piper Sandler Trims Becton Dickinson (BDX) PT on Model Revisions

Y

Bank of America Boosts APD Price Target, Sees Commodity Tailwinds Into 2026

Y

The Most Common Questions Financial Advisors Hear, Answered

Y

Baird Trims Stanley Black & Decker (SWK) PT on Weak Channel Checks

Y

Occidental Petroleum: Buy, Sell, or Hold?

Y

Boston Trust Walden Lets Go of 93,000 Qualys (QLYS) Shares

Y

1 Rock‑Solid Dividend Stock I'd Happily Hold Through Any Market Crash

Y

Prediction: This Will Be Meta's Stock Price in 5 Years

Y

The Buffett Era Is Over: Could This Ultra‑High‑Yield Stock Unravel?

Y

Jim Cramer on Mega Fortune Company: “You Simply Have to Take Some Profits or Else”

Y

Jim Cramer on Insulet Corporation: “It’s Still Too Expensive Because of the GLP-1 Threat”

Y

Jim Cramer on Rivian: “It Looks Like They’re Going to Make It”

Y

Jim Cramer on Dave Inc.: “We Are Going to Sell Fintech”

Y

Jim Cramer Says “We Cannot Be in SoundHound”

Y

Jim Cramer Recommends MP Materials Over Critical Metals Corp.

Y

Jim Cramer Says “PG&E Is a Great Growth Story”

Y

Jim Cramer on Thermo Fisher: “I Think That the Market Has This Wrong”

Y

Jim Cramer Discusses the Recent Performance and Earnings Result of Dow Inc.

Y

Jim Cramer on UnitedHealth: “The Stock Deserves to Be Much Higher”

Y

Jim Cramer Says Johnson & Johnson “Has the Best Pipeline of Potential Blockbusters”

Y

Jim Cramer Says Cardinal Health Is a “Steal”

Y

Jim Cramer on CVS Health: “I Think It’s Only Going to Get Better as the Competition Disappears”

Y

Jim Cramer on Tesla: “I’m Not a Seller of the Future, I’m a Buyer of the Future”

Y

Jim Cramer on Meta: “I Think Mark Zuckerberg Is Being Efficient”

Y

Jim Cramer on ServiceNow: “The Market’s Changed, the Buyers Turned Into Sellers”

Y

Jim Cramer Credits Lip-Bu Tan For an Amazing Performance of Intel

Y

Jim Cramer on Home Depot: “This Is the Stock You Own When You Get Rate Cuts”

Y

Jim Cramer on Lightwave Logic: “Perfect Candidate For Selling Half Your Stock Tomorrow Morning”

Y

Jim Cramer on POET: “Sounds Interesting, But Not 100% Up Interesting, Sell Some”

Y

What Makes Maze Therapeutics (MAZE) One of the Best Oversold Small-Cap Stocks to Buy

Y

Northland Reaffirms Outperform Rating for MiMedx Group (MDXG)

Y

Truist Reiterates Buy Rating for Viridian Therapeutics (VRDN)

Y

Why Does Burford Capital (BUR) Appear so Attractive

Y

TAT Technologies (TATT) Positioned to Capitalize on Long-Term Secular Trends

Y

Mama’s Creations (MAMA) Fuels Confidence Following Q4 Outperformance

Y

Insteel Industries (IIIN) Sits Comfortably With Current Market Position, Following Q2 Announcement

Y

BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO)

Y

Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)

Y

Ennis Inc. (EBF) Delivers In-Line Fourth Quarter Results

Y

Here is Why Altimmune Inc. (ALT) Appears to be an Attractive Penny Stock

Y

Richtech Robotics Inc. (RR) Scaling Abroad Through Strategic Collaboration

Y

EVgo Inc. (EVGO) is One of the Best Shorted Penny Stocks to Look at, Here is Why

Y

ThredUp Inc. (TDUP) Garnering Attention with Mass-Market Resale Network Positioning

Y

Recursion Pharmaceuticals (RXRX) Offers Encouraging Prospects After Setting 2026 Priorities

Y